Latest Insider Transactions at Tango Therapeutics, Inc. (TNGX)
This section provides a real-time view of insider transactions for Tango Therapeutics, Inc. (TNGX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Tango Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Tango Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 20
2024
|
Third Rock Ventures Iv, L.P. |
SELL
Open market or private sale
|
Direct |
162,500
-0.84%
|
$1,950,000
$12.0 P/Share
|
|
Feb 07
2024
|
Barbara Weber Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,457
-0.29%
|
$53,484
$12.62 P/Share
|
|
Feb 07
2024
|
Adam Crystal |
SELL
Open market or private sale
|
Direct |
4,083
-3.3%
|
$48,996
$12.62 P/Share
|
|
Feb 07
2024
|
Daniella Beckman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,817
-1.35%
|
$21,804
$12.62 P/Share
|
|
Feb 07
2024
|
Douglas Barry General Counsel |
SELL
Open market or private sale
|
Direct |
1,354
-2.99%
|
$16,248
$12.62 P/Share
|
|
Feb 06
2024
|
Barbara Weber Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,681
-0.3%
|
$56,172
$12.56 P/Share
|
|
Feb 06
2024
|
Adam Crystal |
SELL
Open market or private sale
|
Direct |
4,288
-3.35%
|
$51,456
$12.56 P/Share
|
|
Feb 06
2024
|
Daniella Beckman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,908
-1.4%
|
$22,896
$12.56 P/Share
|
|
Feb 06
2024
|
Douglas Barry General Counsel |
SELL
Open market or private sale
|
Direct |
1,422
-3.04%
|
$17,064
$12.56 P/Share
|
|
Feb 01
2024
|
Daniella Beckman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,413
+50.0%
|
-
|
|
Feb 01
2024
|
Douglas Barry General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
22,859
+50.0%
|
-
|
|
Feb 01
2024
|
Barbara Weber Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
87,168
+50.0%
|
-
|
|
Feb 01
2024
|
Adam Crystal |
BUY
Grant, award, or other acquisition
|
Direct |
46,599
+50.0%
|
-
|
|
Nov 01
2023
|
Adam Crystal |
SELL
Open market or private sale
|
Direct |
7,507
-8.46%
|
$60,056
$8.39 P/Share
|
|
Oct 16
2023
|
Boxer Capital, LLC |
BUY
Open market or private purchase
|
Direct |
500,000
+5.75%
|
$3,000,000
$6.84 P/Share
|
|
Oct 13
2023
|
Boxer Capital, LLC |
BUY
Open market or private purchase
|
Direct |
750,000
+8.88%
|
$5,250,000
$7.07 P/Share
|
|
Oct 09
2023
|
Boxer Capital, LLC |
SELL
Open market or private sale
|
Direct |
175,000
-2.46%
|
$1,575,000
$9.97 P/Share
|
|
Oct 09
2023
|
Boxer Capital, LLC |
SELL
Open market or private sale
|
Indirect |
50,000
-6.72%
|
$450,000
$9.91 P/Share
|
|
Aug 29
2023
|
John B Ketchum |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
|
Aug 11
2023
|
Boxer Capital, LLC |
BUY
Open market or private purchase
|
Indirect |
475,000
+38.98%
|
$2,375,000
$5.15 P/Share
|
|
Jun 06
2023
|
Lesley Ann Calhoun |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Jun 06
2023
|
Mace Rothenberg |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Jun 06
2023
|
Alexis Borisy |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Jun 06
2023
|
Aaron I. Davis |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Jun 06
2023
|
Malte Peters |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Jun 06
2023
|
Reid M Huber Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Mar 01
2023
|
Adam Crystal |
BUY
Grant, award, or other acquisition
|
Direct |
81,250
+50.0%
|
-
|
|
Mar 01
2023
|
Alan Huang Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,697
+15.91%
|
-
|
|
Mar 01
2023
|
Douglas Barry General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
23,898
+50.0%
|
-
|
|
Mar 01
2023
|
Daniella Beckman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,842
+25.35%
|
-
|
|
Mar 01
2023
|
Barbara Weber Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
89,545
+5.79%
|
-
|
|
Oct 13
2022
|
Boxer Capital, LLC |
BUY
Open market or private purchase
|
Direct |
70,000
+0.97%
|
$280,000
$4.65 P/Share
|
|
Oct 12
2022
|
Boxer Capital, LLC |
BUY
Open market or private purchase
|
Direct |
50,000
+15.7%
|
$200,000
$4.43 P/Share
|
|
Oct 11
2022
|
Boxer Capital, LLC |
BUY
Open market or private purchase
|
Direct |
117,000
+34.87%
|
$468,000
$4.25 P/Share
|
|
Oct 06
2022
|
Boxer Capital, LLC |
BUY
Open market or private purchase
|
Direct |
70,394
+0.99%
|
$281,576
$4.06 P/Share
|
|
Oct 05
2022
|
Boxer Capital, LLC |
BUY
Open market or private purchase
|
Direct |
86,000
+0.61%
|
$258,000
$3.89 P/Share
|
|
Oct 04
2022
|
Boxer Capital, LLC |
BUY
Open market or private purchase
|
Direct |
25,606
+0.37%
|
$76,818
$3.67 P/Share
|
|
Nov 20
2020
|
Bctg Holdings, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,000
-0.06%
|
$0
$0.01 P/Share
|